Comparison of behavioral treatment conditions in buprenorphine maintenance.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Addiction

• Publication date

  2013-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/add.12266PMID 23734858PMCID PMC3866908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are theories of learning necessary?

  2013cited by this paper
• A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.

  2013cited by this paper
• Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.

  2011cited by this paper
• Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.

  2008cited by this paper
• Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

  2006influential reference
• Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.

  2005cited by this paper
• A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.

  2005cited by this paper
• Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure

  2005cited by this paper
• A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior

  2004cited by this paper
• Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.

  2004cited by this paper
• Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

  2004cited by this paper
• Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

  2003cited by this paper
• The Clinical Opiate Withdrawal Scale (COWS)

  2003influential reference
• Clinical efficacy of buprenorphine: comparisons to methadone and placebo.

  2003cited by this paper
• A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence.

  2002cited by this paper
• Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

  2002cited by this paper
• Voucher-based incentives. A substance abuse treatment innovation.

  2002cited by this paper
• Assertive Community Treatment Literature Review Prepared For : Health Care and Financing Administration ( HCFA ) And Substance Abuse and Mental Health Services Administration ( SAMHSA )

  2001cited by this paper
• Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

  2001cited by this paper
• Office-based treatment for opioid dependence: reaching new patient populations.

  2001cited by this paper
• Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.

  2000cited by this paper
• Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet.

  2000cited by this paper
• Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

  2000cited by this paper
• A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar.

  2000cited by this paper
• Initial abstinence and success in achieving longer term cocaine abstinence.

  2000cited by this paper
• One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment.

  2000cited by this paper
• Theoretical and empirical foundations of contingency management treatments for drug abuse.

  1999cited by this paper
• Motivating behavior change among illicit-drug abusers: Research on contingency management interventions.

  1999cited by this paper
• Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.

  1998cited by this paper
• Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

  1998cited by this paper
• The influence of alternative reinforcers on cocaine use and abuse: a brief review.

  1997cited by this paper
• Treatment effectiveness score as an outcome measure in clinical trials.

  1997cited by this paper
• Effects of adding behavioral treatment to opioid detoxification with buprenorphine.

  1997cited by this paper
• Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

  1996cited by this paper
• A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

  1996influential reference
• Buprenorphine as a Pharmacotherapy for Opiate Addiction: What Dose Provides a Therapeutic Response?

  1996cited by this paper
• An intensive outpatient approach for cocaine abuse treatment. The Matrix model.

  1995cited by this paper
• Outpatient behavioral treatment for cocaine dependence: One-year outcome.

  1995cited by this paper
• One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.

  1994cited by this paper
• Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.

  1994cited by this paper
• Influence of an alternative reinforcer on human cocaine self-administration.

  1994cited by this paper
• The Fifth Edition of the Addiction Severity Index.

  1992influential reference
• Clinical trials in psychiatry: should protocol deviation censor patient data?

  1992cited by this paper
• A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy.

  1991cited by this paper
• Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings.

  1986influential reference
• Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers.

  1985cited by this paper
• Psychotherapy for opiate addicts. Does it help?

  1983cited by this paper
• Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines.

  1980cited by this paper
• Reducing benzodiazepine self-administration with contingent reinforcement.

  1979cited by this paper

• Rationale and design of a three-arm randomized clinical trial to improve drug use and retention in care of people with opioid use disorder on buprenorphine: OVERCOME II study.

  2026cites this paper
• Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes.

  2026cites this paper
• Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder

  2025cites this paper
• Approved medications for opioid use disorder : current update

  2025cites this paper
• Association of federal poverty level with healthcare expenditures among opioids users in the United States (2008–2019): a serial cross-sectional study

  2025cites this paper
• “There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits

  2025cites this paper
• Clinical and psychosocial factors affecting outcome with sublingual buprenorphine-naloxone substitution in opioid dependence in terms of abstinence and compliance-A two years longitudinal study

  2024cites this paper
• Association between high-threshold practices and buprenorphine treatment termination.

  2024cites this paper
• Capturing the Full Range of Buprenorphine Treatment Response.

  2024cites this paper
• Contingency management for monosubstance use disorders: Systematic review and assessment of predicted versus obtained effects.

  2024cites this paper
• Relationship of hub and treatment characteristics with client outcomes in the initial Washington State hub and spoke cohort.

  2024cites this paper
• Group counselling can prolong the remission period in Opioid Use Disorder patients after detoxification and enhance social support, self-efficacy and hopelessness levels in patients and their families in Turkey

  2024cites this paper
• Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder

  2024cites this paper
• Perspectives and sentiments on contingency management from people who use methamphetamine.

  2023cites this paper
• Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care.

  2023cites this paper
• Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids

  2023cites this paper
• “I Just Don’t Feel Heard”: A Case Study on Opioid Use Disorder and Pain Management

  2023cites this paper
• Discounting of employment opportunities with urine drug testing requirements in opioid users enrolled in the Therapeutic Workplace

  2023cites this paper
• Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary

  2022cites this paper
• Contingency Management for Drug Use Disorders: Meta-Analysis and Application of Tolin's Criteria.

  2022cites this paper
• Factors associated with counselling adherence in opioid treatment programs.

  2022cites this paper
• Medications for Opioid Use Disorder Do Help Patients.

  2022cites this paper
• Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review.

  2022cites this paper
• Opioid Use Disorder Diagnosis and Management.

  2022cites this paper
• Differences in buprenorphine treatment quality across physician provider specialties.

  2022cites this paper
• Expanding Buprenorphine Use in Primary Care: Changing the Culture.

  2022cites this paper
• Psychosocially-Assisted Pharmacological Treatment of Opioid Dependent Adults: A Systematic

  2022cites this paper
• Shifting Focus to Evidence-Based Management of Substance Use Disorders

  2022cites this paper
• The Impact of Individual Counseling on Treatment for Opioid Use

  2022cites this paper
• Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.

  2021cites this paper
• Treatment of opioid use disorder in primary care

  2021cites this paper
• Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study.

  2021cites this paper
• Comparative benefits of social housing and buprenorphine on wheel running depressed by morphine withdrawal in rats

  2021cites this paper
• Contingency Management for Patients Receiving Medication for Opioid Use Disorder

  2021cites this paper
• Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

  2021cites this paper
• Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders.

  2021cites this paper
• A mental health professional survey of cognitive-behavioral therapy for the treatment of opioid use disorder.

  2021cites this paper
• Substance use trajectories and impacts of drug treatment among people who use illicit drugs in Vancouver, Canada

  2021cites this paper
• Opioid Use Disorder Pharmacotherapy: A Historical Perspective on How We Practice, and Why

  2021cites this paper
• Reflections on Person-Centered Group Therapy from Clients in Opioid Treatment

  2021influential citation
• Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population

  2021cites this paper
• Evidence-Based Treatment of Young Adults With Substance Use Disorders.

  2021cites this paper
• Associations between baseline opioid use disorder severity, mental health and biopsychosocial functioning, with clinical responses to computer-assisted therapy treatment

  2021cites this paper
• Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation

  2021cites this paper
• Cost-effectiveness of Treatments for Opioid Use Disorder.

  2021cites this paper
• Telehealth Approaches to Improve Opioid Use Care in Pregnancy.

  2021cites this paper
• Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial

  2020cites this paper
• Psychosocial intervention utilization and substance abuse treatment outcomes in a multisite sample of individuals who use opioids.

  2020cites this paper
• Effects of abstinence from opioids on self-reported craving and sleep

  2020cites this paper
• Psychosocial Interventions in Office-Based Opioid Treatment: A Systematic Review

  2020cites this paper
• Long-Term Efficacy of Medication-Assisted Treatment of Opioid Addiction: A Systematic Literature Review—Part 1

  2020cites this paper
• Canadian Guidelines on Opioid Use Disorder Among Older Adults

  2020cites this paper
• Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders

  2020cites this paper
• Treatment of Opioid Use Disorder in the Elderly

  2020cites this paper
• Internet‐based cognitive-behavioral therapy (I-CBT) for problem drinkers: systematic review and meta-analysis (Preprint)

  2020cites this paper
• National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.

  2020cites this paper
• Perspectives of people with opioid use disorder on improving addiction treatments and services

  2020cites this paper
• Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations.

  2020cites this paper
• Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials

  2020influential citation
• Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses

  2020influential citation
• A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder

  2020cites this paper
• Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States.

  2020cites this paper
• Group Treatment Effectiveness for Substance Use Disorders: Abstinence vs. Harm Reduction

  2020cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Buprenorphine Treatment for Opioid Use Disorder in Community‐Based Settings: Outcome Related to Intensity of Services and Urine Drug Test Results

  2020cites this paper
• Buprenorphine treatment for opioid use disorder: recent progress

  2019cites this paper
• Enhancing Treatment Access and Effectiveness: Toward Patient-Centered Models of Care

  2019cites this paper
• Killing More than Pain: Etiology and Remedy for an Opioid Crisis

  2019cites this paper
• Psychosocial Approaches in the Treatment of Opioid Use Disorders

  2019cites this paper
• Psychosocial Supports in Medication-Assisted Treatment : Recent Evidence and Current Practice Final Report on Current Practices of Psychosocial Supports in MAT

  2019cites this paper
• Engaging an Unstably Housed Population with Low-Barrier Buprenorphine Treatment at a Syringe Services Program: Lessons Learned from Seattle, Washington

  2019cites this paper
• Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice

  2019cites this paper
• Opioid Use Disorder: Medical Treatment Options.

  2019cites this paper
• U.S. Department of Health and Human Services Assistant Secretary for Planning and Evaluation Office of Disability, Aging and Long-Term Care Policy

  2019cites this paper
• Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation

  2019cites this paper
• A Systematic Review of the Effectiveness of Buprenorphine for Opioid Use Disorder Compared to Other Treatments: Implications for Research and Practice

  2019cites this paper
• Treating Opioid Dependence: Pain Medicine Physiology of Tolerance and Addiction.

  2019cites this paper
• Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialties.

  2019cites this paper
• Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder.

  2019cites this paper
• Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation

  2019cites this paper
• State-of-The-Art Treatment of Opioid Use Disorder

  2019cites this paper
• Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation

  2019cites this paper
• The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

  2019cites this paper
• Medication for the Treatment of Opioid Use Disorder

  2019cites this paper
• Treatment of Opioid Dependence

  2018cites this paper
• Trends and mental health correlates of nonmedical opioid use among criminal justice-involved African American men.

  2018cites this paper
• Attentional bias in opioid users: A systematic review and meta-analysis.

  2018cites this paper
• Fall 12-12-2014 An Evaluation of Mental Health and Methadone : Anxiety , Depression , and Drug Use

  2018influential citation
• Pharmacological and Behavioral Treatment of Opioid Use Disorder

  2018cites this paper
• A Systematic Review of Psychosocial Interventions in Treatment of Opioid Addiction

  2018influential citation
• Addressing opioid use disorder: The role in pharmacotherapy barriers

  2017cites this paper
• The Prescription Opioid Addiction Treatment Study: What have we learned

  2017cites this paper
• Update on Barriers to Pharmacotherapy for Opioid Use Disorders

  2017cites this paper
• What does it really mean to be providing medication-assisted treatment for opioid addiction ?

  2017cites this paper
• Treatment of opioid dependence with buprenorphine: current update

  2017cites this paper
• Case 37-2017. A 36-Year-Old Man with Unintentional Opioid Overdose.

  2017cites this paper
• Contingency Management interventions for non-prescribed drug use during treatment for opiate addiction: A systematic review and meta-analysis

  2017influential citation
• Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio

  2017cites this paper
• Perspectives on the Pharmacological Treatment of Heroin Addiction

  2017cites this paper
• ‘Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation

  2017cites this paper